PPT Slide
E. Gene therapy - Combines the concepts underlying tumor cell vaccines with those underlying cytokine therapy or to break tolerance. This is accomplished by expressing genes coding for cytokines, costimulatory molecules, or MHC molecules.
F. Adoptive immunotherapy with antitumor T cells, tumor-infiltrating lymphocytes (TIL), or lymphokine-activated killer (LAK) cells - Problems include difficulties in growing the large numbers of cells required, loss of antigenic specificity for T cells, o